David Saadoun
Overview
Explore the profile of David Saadoun including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
307
Citations
6627
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Gerard A, Vieira M, Cohen A, Hassanaly O, Lambert J, Saadoun D
Semin Arthritis Rheum
. 2025 Feb;
71:152660.
PMID: 39978288
Background: The combination of different biological and targeted synthetic DMARDs (i.e., combotherapy) has recently emerged in the management of immune-mediated inflammatory diseases (IMID). However, real-life data across specialities and prognostic...
2.
Martin A, Caron S, Marcotte M, Bronnec P, Garneret E, Martel N, et al.
iScience
. 2025 Jan;
28(1):111563.
PMID: 39868044
Alpha-kinase 1 (ALPK1) is an immune receptor sensing the bacterial nucleotide sugar ADP-heptose. ALPK1 phosphorylates TIFA leading to its oligomerization and downstream NF-κB activation. Specific mutations in are associated with...
3.
Espitia O, Bruneval P, Liozon E, Pouchot J, de Boysson H, Gaudric J, et al.
J Autoimmun
. 2025 Jan;
151:103360.
PMID: 39826312
Background: Non-infectious aortitis encompasses various histological patterns, but their specific cardiovascular outcomes remain unclear. Objective: To evaluate the mortality associated with non-infectious surgical thoracic aortitis. Methods: This retrospective multicenter study...
4.
Cacoub P, Vieira M, Saadoun D
N Engl J Med
. 2024 Dec;
391(23):2280.
PMID: 39665671
No abstract available.
5.
Saadoun D, Maalouf G, Vieira M, Trad S, Lazaro E, Sacre K, et al.
NEJM Evid
. 2024 Oct;
3(11):EVIDoa2300354.
PMID: 39437137
Background: Cyclophosphamide and infliximab are recommended as induction therapies for severe Behçet's syndrome. Whether infliximab is safer and more effective than cyclophosphamide in treating severe Behçet's syndrome is not known....
6.
Cacoub P, Vieira M, Saadoun D
N Engl J Med
. 2024 Oct;
391(15):1426-1439.
PMID: 39413378
No abstract available.
7.
Hassler S, Lorenzon R, Binvignat M, RIbet C, Roux A, Johanet C, et al.
J Autoimmun
. 2024 Oct;
149:103318.
PMID: 39357469
Background: Autoimmune and inflammatory diseases (AIDs) are a heterogeneous group of disorders with diverse etiopathogenic mechanisms. This study explores the potential utility of family history, together with present and past...
8.
Ghayad E, Maalouf G, Mekinian A, Emmi G, Vieira M, Mirouse A, et al.
Ann Rheum Dis
. 2024 Sep;
83(12):1794-1796.
PMID: 39317416
No abstract available.
9.
La Rosa A, Groh M, Martin A, Tran Ba S, Cucherousset N, Mouriaux F, et al.
BMJ Open Ophthalmol
. 2024 Sep;
9(1).
PMID: 39313294
Purpose: To better characterise the effects of corticosteroids on the course of pure idiopathic orbital inflammation syndrome (pIOIS). Methods: This was a national, multicentre, prospective, non-interventional cohort study (). Among...
10.
Regnier P, Montardi C, Maciejewski-Duval A, Marques C, Saadoun D
PLoS One
. 2024 Sep;
19(9):e0308970.
PMID: 39298534
PUPAID is a workflow written in R + ImageJ languages which is dedicated to the semi-automated processing and analysis of multi-channel immunofluorescence data. The workflow is designed to extract fluorescence...